Beatriz Losada, María del Carmen Pantín, Javier de la Rubia, Israel Manzanedo and David Gutiérrez
Colorectal cancer is the second cause of death in Spain (20% diagnosed in stage IV), improving survival in recent years thanks to chemotherapy and metastatic surgeries. With regard to a patient diagnosed with native stage IV KRAS colon adenocarcinoma (peritoneal, hepatic), the subject of cytoreduction with HIPEC (intraperitoneal hyperthermic chemotherapy) and the factors that influence the tumor response are reviewed.
ఈ కథనాన్ని భాగస్వామ్యం చేయండి